Markets for Blood Testing and Typing

 
   Single User - $3,995
   Site License (one location, 10 users) - $5,500
   Corporate License - $7,990



Loading...
Published Jun 9, 2017 | 210 Pages | Pub ID: KLI15378333

Markets for Blood Testing and Typing Post-Zika

The global blood testing and typing industry has experienced strong growth in recent years and growth will remain solid though 2021 and 2026 as a result of:
  • Aging populations in the U.S., Europe and Japan;
  • Rising rates of disease diagnosis and treatment;
  • Ongoing technology advancements/new product introductions and indications;
  • Expansion of health coverage in the U.S. via health care reform; and
  • Continued strong promotion of blood donation by collection agencies.
The Zika outbreak, with more than 4,000 U.S. reported through early 2017 and outbreaks in several Latin American countries, has further underscored the importance of comprehensive blood screening and heightened industry imperatives to ensure blood supply safety.

This Kalorama Information report, Blood Testing and Typing Post-Zika details sales estimates for each market segment represent global revenues and are expressed in current dollars. Estimates are provided for 2011 to 2016 and forecasts are provided through 2021 and 2026. Historical information was gathered from a wide variety of published sources including company reports, government documents, legal filings, trade journals, newspapers and business press, analysts’ reports and other sources. Interviews with company representatives were conducted to capture the perspectives from industry participants’ point of view and assess trends.

Excluded from this report are blood testing products used in biopharmaceutical processing/manufacturing/research, and veterinary tests. Also excluded are blood products for transfusion such as red blood cells (RBCs), immunoglobulin products, synthetic blood/albumin, etc. as well as blood testing services/laboratories.

Blood Testing and Typing Product Segmentation

The total global market for blood testing and typing products includes products and devices used in blood banking/donations as well as products used otherwise. This can also be thought of as testing and typing on pooled blood donations (blood bank) versus individual blood samples. In both of these segments, the following products are used:
  • Pathogen screening by immunoassay;
  • Pathogen screening by NAT;
  • Blood typing and grouping;
The global blood industry represents a diverse assortment of companies, groups and organizations that provide for the safe collection, testing, storage and delivery of human blood and blood products for transfusion. These blood transfusions are of critical importance to those with both acute and chronic medical conditions in which blood is depleted or non-functioning, since more than 9 million Americans and Europeans would die each year without transfusions.

The following sections provide highlights of the blood industry’s ongoing technological development and a background on the physiological aspects of human blood, which will form the basis for understanding the blood testing and typing industries profiled in detail in this report’s later chapters.This Kalorama Information report, Blood Testing and Typing Post-Zika details sales estimates for each market segment represent global revenues and are expressed in current dollars. Estimates are provided for 2011 to 2016 and forecasts are provided through 2021 and 2026. Historical information was gathered from a wide variety of published sources including company reports, government documents, legal filings, trade journals, newspapers and business press, analysts’ reports and other sources. Interviews with company representatives were conducted to capture the perspectives from industry participants’ point of view and assess trends.

Excluded from this report are blood testing products used in biopharmaceutical processing/manufacturing/research, and veterinary tests. Also excluded are blood products for transfusion such as red blood cells (RBCs), immunoglobulin products, synthetic blood/albumin, etc. as well as blood testing services/laboratories.

The total global market for blood testing and typing products includes products and devices used in blood banking/donations as well as products used otherwise. This can also be thought of as testing and typing on pooled blood donations (blood bank) versus individual blood samples. In both of these segments, the following products are used:
  • Pathogen screening by immunoassay;
  • Pathogen screening by NAT;
  • Blood typing and grouping;
The global blood industry represents a diverse assortment of companies, groups and organizations that provide for the safe collection, testing, storage and delivery of human blood and blood products for transfusion. These blood transfusions are of critical importance to those with both acute and chronic medical conditions in which blood is depleted or non-functioning, since more than 9 million Americans and Europeans would die each year without transfusions.

The following sections provide highlights of the blood industry’s ongoing technological development and a background on the physiological aspects of human blood, which will form the basis for understanding the blood testing and typing industries profiled in detail in this report’s later chapters.
In this report,  {{key}} appears {{searchResults.reportMatchCounts[value]}} times
We were unable to search inside this report.
No results matched your search criteria.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.